Background-Associations between hospital volume and the risk of stroke or death following carotid endarterectomy (CEA) and carotid artery stenting (CAS) on a national level in Germany were analyzed. Methods and Results-Secondary data analysis using microdata from the nationwide statutory German quality assurance database on all surgical or endovascular carotid interventions on the extracranial carotid artery between 2009 and 2014. Hospitals were categorized into empirically determined quintiles according to the annual case volume. The resulting volume thresholds were 10, 25, 46, and 79 for CEA and 2, 6, 12, and 26 for CAS procedures. The primary outcome was any stroke or death before hospital discharge. For risk-adjusted analyses, a multilevel regression model was applied. The analysis included 161 448 CEA and 17 575 CAS procedures. In CEA patients, the crude risk of stroke or death decreased monotonically from 4.2% (95% confidence interval, 3.6%-4.9%) in low-volume hospitals (first quintile 1-10 CEA per year) to 2.1% (2.0%-2.2%) in hospitals providing ≥80 CEA per year (fifth quintile; P<0.001 for trend). The overall risk of any stroke or death in CAS patients was 3.7% (3.5%-4.0%), but no trend on annual volume was seen (P=0.304). Riskadjusted analyses confirmed a significant inverse relationship between hospital volume (categorized or continuous) and the risk of stroke or death after CEA but not CAS procedures. Conclusions-An inverse volume-outcome relationship in CEA-treated patients was demonstrated. No significant association between hospital volume and the risk of stroke or death was found for CAS. (Circ Cardiovasc Interv. 2016;9:e004171.
A high hospital volume has been demonstrated to be associated with better health outcomes for numerous surgical procedures and conditions. [1] [2] [3] [4] Therefore, it could be proposed that this may also be the case for carotid endarterectomy (CEA) and carotid artery stenting (CAS). From a theoretical point of view, the relationship between hospital volume and improved health outcome may be explained by a latent (not directly measurable) construct (eg, routine or experience), which may be associated with (infra)structural conditions and procedural-, individual-, or team-related factors that differ between low-and high-volume hospitals. For CEA, previous publications have shown an inverse relationship between the periprocedural adverse event rate and annual volume (either with regard to the hospital [5] [6] [7] or surgeon [8] [9] [10] . A recent meta-analysis-including 25 reports with >800 000 CEAsrevealed that perioperative adverse event rates (stroke and death, all-cause death, and any stroke) decreased as the annual hospital volume of CEAs increased, with an annual critical volume threshold of 79 CEA. 11 For CAS, few studies have focused on the volume-outcome relationship, but the reported results were ambiguous. [12] [13] [14] [15] [16] Most studies were based on the administrative data from hospitals located in North America, the United Kingdom, or Finland. 6, 11 Nevertheless, Holt et al 11 suggested that volume criteria should be analyzed and adapted to each healthcare system individually to reduce perioperative risks following CEA or CAS.
Therefore, the purpose of this study was to analyze the association between hospital volume and risk of stroke or death following CEA and CAS under everyday conditions in Germany. The study results should facilitate generation of new hypotheses for experimental studies investigating minimum-volume thresholds for CEA and CAS procedures and may support discussions surrounding evidence-based health policy making concerning centralization of vascular services.
Methods

Legal Basis and Data Acquisition
The basic methods have already been described elsewhere. 16a In short, this secondary data analysis is based on the nationwide statutory quality assurance database operated by the Institute for Applied Quality Improvement and Research in Health Care (AQUA Institute). In 2009, the AQUA Institute was commissioned and authorized by the German Federal Joint Committee (G-BA, legal basis §91 German Social Security Code part 5, SGB V 17 ) to develop and implement external quality assurance in the German healthcare system pursuant to §137a SGB V. Through 2015, the AQUA Institute was also mandated to conduct data validation, data analysis, and publication of annual quality reports. In accordance with the G-BA directive concerning measures of trans-sectoral and inpatient quality assurance, 18, 19 reporting of quality assurance data is mandatory for all inpatient procedures performed to treat narrowed internal carotid arteries (ICA; extracranial part of the ICA, including atherosclerotic plaques involving also the carotid bifurcation). These reports include data on almost all inpatients. 19 22 ). Nonanonymous patient-level data hosted by the AQUA Institute were processed and analyzed in conformance with the German data protection law. Legal conformity was controlled by staff members at the AQUA Institute (T.K. and T.B.).
Data Processing and Patient Categorization
The coding of variables, extracted from the documentation forms provided by the AQUA Institute, was harmonized for the period 2009 to 2014. 23 Because data were available on a procedure-related basis only, the term case would be more precise. Nevertheless, we prefer to use the term patient.
Patients were categorized into 3 indication groups according to the German quality assurance procedure: 
Hospital Volume and Primary Outcome Event Rate
Hospital volume was defined as the annual number of procedures (patients) linked to the same hospital site code (pseudonyms).
Overall hospital volume was calculated separately for CEA and CAS. As no evidence-based categorization of hospital volume exists, hospitals were grouped empirically into quintiles (QU1-QU5, where QU1=low volume and QU5=high volume). Because annual volume is a property of the level of the hospitals (second level), calculation of quintiles was based on the annual hospital volume (separately for CEA and CAS) to obtain an equal number of hospitals in each category ( Table 1 ). The primary outcome of this study was any inhospital stroke or inhospital mortality (all-cause death). The neurological outcome was directly coded in a variable either as none, transient ischemic attack (TIA), or stroke. Grading of neurological deficit was documented in a separate variable according to the modified Rankin scale. Diagnosis of TIA or stroke was based on clinical/neurological examination with or without further assessment by computed tomography or magnetic resonance imaging. Qualification of the physician performing the examination before and after the procedure is coded in 2 separate variables (preprocedural/postprocedural neurological assessment by a specialist in neurology: yes or no, respectively). For the purpose of this study, only strokes (fixed neurological deficits occurring during or after the procedure) were considered as outcome events. Hospital-specific annual outcome rates were calculated by dividing the number of primary outcome events by the total number of procedures performed in the same year and in the same hospital. The secondary outcomes were any inhospital major stroke or inhospital mortality (all-cause death) and inhospital mortality (all-cause death alone). The primary and the secondary outcomes defined above were used as the dichotomous independent variables of the regression analyses.
Statistical Analyses
Nominal and ordinal variables were analyzed using contingency tables. For normally distributed variables, the arithmetic mean and the SD were calculated. Variables with skewed distribution were analyzed by calculating the median and the 25% and 75% percentiles (Q 0.25 and Q 0.75 ).
To calculate adjusted relative risks (RRs) and the corresponding 95% confidence interval (CI) for the volume categories and to account for
WHAT IS KNOWN
• A high hospital volume has been demonstrated to be associated with better health outcomes for a variety of surgical procedures and conditions. • A volume-outcome relationship may also exist for carotid endarterectomy and carotid artery stenting.
WHAT THE STUDY ADDS
• This study reveals that there is a significant inverse volume-outcome relationship in patients treated with carotid endarterectomy under real-life conditions in Germany.
• In carotid artery stenting patients, no volume-outcome association was seen, but sample size may have been too low to properly evaluate the volumeoutcome relationship for carotid artery stenting.
confounding and clustering of patients within hospitals, a multilevel Poisson regression model was applied. [24] [25] [26] [27] [28] [29] The variables such as age, sex, American Society of Anesthesiologists category, neurological status on admission (group A: asymptomatic; group B: transient monocular blindness, TIA, and stroke; and group C: crescendo transient ischemic attack, stroke-in-evolution, etc), degree of ipsilateral/contralateral stenosis, periprocedural antiplatelet therapy, formal assessment by a neurologist before and after the procedure, intraprocedural neurophysiologic monitoring, and other treatment-specific features (for CEA: surgical technique, type of anesthesia, shunt use, intraoperative completion study, and clamping time; for CAS: use of a protection system, stent type, and stent cell design) were entered into the model as fixed-effect. The hospital site code specific for the year of treatment was entered as random-effect (random intercept only). The structure of the covariance matrix (within-hospital correlation structure) was specified as unstructured. The variables to be entered into the model were selected a priori, according to a prespecified analysis plan that was developed with regard to the literature and theoretical considerations. The model fit was assessed by quantile-quantile plots of the random effects and by plotting the random effects against the hospital volume. As the database can be considered complete on a national level, calculation of CIs or P values would not have been necessary or meaningful but were calculated to estimate possible variability in future years.
Because the cut-off values for grouping of volume categories were arbitrary (even when estimated empirically), an additional analysis using annual hospital volume as a continuous variable was performed (on the basis of an exploratory approach). Hospital volume was modeled as a polynomial (first to fifth degree) using the model structure described above. To analyze the robustness of polynomial modeling, we performed a sensitivity analysis by excluding annual hospital volume outliers, which were identified according to the definition used in the Statistical Package for the Social Sciences (IBM, Armonk, NY): Q 0.25 /Q 0.75 and a step of 1.5× the interquartile range. Relative model fit was assessed using the Akaike information criterion and likelihood ratio tests.
Exploratory investigation of robustness of the volume-outcome relationship was also performed by including the specialization of the hospital department in the model. This variable refers to the unit or ward that cared for the patient, which was not necessarily the same department that provided the CEA or CAS. In total, there were 745 missing values (4.2%) in the CAS group (not heterogeneous across hospital volume categories, χ 2 test, P=0.072) and 4 409 missing values (2.7%) in the CEA group (heterogeneous across volume categories, χ 2 test, P<0.001). In the latter group, 99.7% of missing values were because of missing information on clamping time. In the CAS group, 99.3% missing values were because of missing information on stent type/design. To prove robustness of analyses, we performed regression analyses (as specified above) for CEA and CAS omitting clamping time and stent type/ design, respectively.
For data processing and statistical analysis, the statistical package R (version 3.2.1; The R Foundation, http://www.r-project.org) and SAS software (version 9.4, Microsoft Windows, 2015 SAS Institute Inc, Cary, NC) were used. The significance level was set to α=0.05.
Results
From 2009 to 2014, 182 033 procedures involving the ICA (also for CAS since 2012) were recorded in the quality assurance database. After excluding the patients in whom (1) CAS was converted to CEA (n=68), (2) CAS/percutaneous transluminal angioplasty was performed only for the purpose of intracranial approach (n=812), and (3) patients who could not be classified into one of the three indication groups because of incomplete or unclear information (n=2130), 161 448 CEA and 17 575 CAS procedures were available for further analysis.
From 2009 to 2014, CEA was performed in 545 to 574 hospitals with a median annual volume of 35 surgical procedures (Q 0.25 -Q 0.75 14-68; Table 1 ). From 2012 to 2014, CAS was performed in 365 to 367 hospitals, with a median hospital volume of 9 (Q 0.25 -Q 0.75 3-22; Table 1 ). Further details on hospitals' and patients' characteristics are given in Tables 1 and 2 . Patient management and treatment details are stated in Tables I through VI in the Data Supplement).
Of the surgically treated patients, 3820 suffered a stroke before discharge or died (2.4%; Table 3 ). In the CAS group, the primary outcome event occurred in 653 patients (3.7%; Table  3 ). In CEA patients, the crude rate of stroke or death decreased monotonically from 4.2% in the first quintile to 2.1% in the fifth quintile (P<0.001 for trend). No such trend was seen in CAS patients (P=0.304). Crude outcome event rates stratified by indication group are given in Table VII depicted in Figures 1 and 2 for CEA and CAS, respectively. The risk of any stroke or death following CEA declines when volume increases but does not further decrease with increasing volume in hospitals performing ≥80 CEAs per year. This was also the case for the secondary outcome major strokes or deaths. In contrast, no statistically significant association between annually performed CAS procedures and outcome events was seen; only the risk of death was significantly lower in hospitals performing ≥27 CAS annually compared with hospitals performing 13-26 CAS per year. About the explorative modeling of hospital volume as a continuous variable, optimal relative model fit was achieved when volume was modeled as a third-degree polynomial for CEA and as a first-degree polynomial (linear term) for CAS patients. For sensitivity analysis, 3049 CEA and 636 CAS procedures were excluded, clustered by year in 6 surgical and 3 endovascular units, respectively. After the exclusion of outliers, the relative model fit was optimal when volume was modeled as a third-degree polynomial in CEA and as a second-degree polynomial for CAS procedures. Relative risk of stroke or death as a continuous function of annual hospital volume is depicted in Figures III and IV in the Data Supplement. Inclusion of the variable department did not substantially affect the volume-outcome relationships (difference in RRs <0.1). Omitting clamping time and stent/type in the regression analyses of CEA and CAS procedures, respectively, did not substantially alter the main results (changes of RRs and CIs were limited to the second decimal place).
Discussion
A significant volume-outcome relationship in patients treated with CEA but not CAS was observed. However, "absence of evidence is not evidence of absence." 30 Nevertheless, this study-with quasicomplete clinical patient data (versus administrative data)-reflects the provision of health services to patients with carotid stenosis under real-life conditions in Germany.
Carotid Endarterectomy
The crude risk of any inhospital stroke or death decreased monotonically from 4.2% in hospitals with 10 or fewer CEA per year to 2.1% in hospitals with an annual volume of ≥80 CEAs. These findings are in accordance with the results of a recent metaanalysis of 25 studies with >800 000 patients by Holt et al, 11 who reported that the odds of postoperative stroke or death were significantly lower in high-volume compared with low-volume hospitals (threshold: 79 CEA per year; odds ratio, 0.78; 95% CI, 0.64-0.92). When applying the same threshold to our data, the odds ratio was 0.81 (95% CI, 0.76-0.87), which matches well to the data of Holt et al. 11 No significant volume-outcome effect was found by Gonzales et al, 12 possibly for the following reasons: the annual hospital volume was based only on the sum of CEA and CAS procedures enrolled in the CREST study (Carotid Revascularization Endarterectomy versus Stenting Trial); the total number of patients was smaller (1240), resulting in a lower probability of detecting an actually existing effect (power); patients and providers of CEA were selected according to the study protocol; and the applied outcome included inhospital/30-day events and ipsilateral strokes ≤4 years postprocedure. Thus, the disagreement between our findings and those of Gonzales et al 12 is not contradictory. Pieper et al 2 also reviewed the impact of CEA volume on the risk of stroke or death; however, conclusions were based mainly on the comprehensive review by Holt et al. 11 The risk of stroke or death did not further decrease with annual volume in hospitals performing ≥80 CEAs per year (Figure 1 ), which is in partial contrast to findings of Nazarian et al, 8 showing a significantly lower risk of death following CEA in hospitals with volumes of >130 per year versus <130 per year. As the latter study refers only to mortality and included only 2 hospitals in the high-volume category, these data may lack generizability. However, in a meta-analysis, Halm et al 1 showed that mortality following CEA was lower in high-volume hospitals (median absolute difference in mortality rate for high versus low volume=0.4%, range −0.5% to 1.8%), although the negative values included in the latter range indicate that, in some cases, also high-volume hospitals had higher mortality rates than low-volume hospitals. The latter findings are in accordance with our exploratory analyses using annual hospital volume as a continuous variable. The risk of stroke or death increased again in high-volume centers ( Figure I in the Data Supplement), which is likely due to outliers with high leverage in the regression model ( Figure II in the Data Supplement). Nevertheless, excluding these outliers for sensitivity analysis, a slight rebound of the risk of stroke or death in centers providing more than ≈100 cases per year cannot be negated. Three possible underlying mechanisms might explain these results: first, a protective effect of routine or training leading to a lower risk of stroke or death when annual volume increases [31] [32] [33] ; second, a ceiling effect limiting the protective effect of routine above a certain annual volume; and third, a selection effect (active or passive) leading to a higher proportion of patients with risk factors that were not collected in the database (eg, challenging vessel morphology or unfavorable medical conditions) in larger hospitals.
Carotid Artery Stenting
In our study, no evidence for an association between the annual volume of CAS procedures and the risk of any inhospital stroke or death was found. A significantly lower than average risk of stroke or death might only be suggested in hospitals providing more than ≈110 CAS per year ( Figure  IV in the Data Supplement). Because <5% of all centers provide >53 CAS per year, these results should be interpreted with caution. This is in line with the findings of Hawkins et al, 13 who analyzed clinical registry data from 19 381 patients treated with CAS in 188 hospitals. Multivariable analyses accounting for selected risk factors and clustering of patients revealed that the annual hospital volume was not a significant predictor of inhospital stroke or death (P=0.09). 13 This is underlined by publications from Sidawy et al 15 and Gonzales et al, 12 who analyzed data from the Society for Vascular Surgery Vascular Registry and the CREST trial, respectively. In these studies, hospital volume was categorized into tertiles (thresholds of 25 and 50/51 CAS per year) but did not show any impact on mortality or stroke risk. 12, 15 In contrast, Epstein et al 34 -retrospectively analyzing >22 000 Medicare beneficiaries-showed that a higher 2-year case volume was significantly associated with lower mortality (with respect to the crude and risk-adjusted rates). Two other studies using administrative data from the nationwide inpatient sample revealed that a higher annual hospital volume was associated with a lower risk of stroke but no significant association with postprocedural death. 14, 16 In the latter reports, methodological heterogeneity may have biased the results, which-in turnreduces comparability with our findings. First, the definition of hospital volume differed and was included either as a metric 13, 14 or dichotomous variable, 16 or it was categorized into tertiles 12, 15 or with regard to a 2-year period. 34 Second, the calculation of hospital volume was based on different cohorts (eg, all patients in database, 15 only asymptomatic patients, 16 or only in-trial patients 12 ). Third, risk-adjusted analyses were not performed, or differing combinations of variables were used. Final, the definitions of outcome events differed and were based either on clinical data 12, 13, 15 or administrative hospital discharge records 14, 16 (eg, International Classification of Diseases-9 codes). The absence of a volume-outcome effect for CAS procedures might be because of at least 2 reasons. First, either the effect or the sample size, or both, is too small to distinguish an existing effect from background noise. In this case, the question remains whether such a small effect would be of any relevance to the population about the provision of carotid surgery. Second, the inclusion of CAS procedures into the statutory quality assurance program (January 2012) and publication of the German-Austrian Guideline on carotid procedures (August 2012) might also have influenced the indication for treatment and subsequent selection of the treatment modality. Therefore, it might be possible that-in smaller centers-CAS is performed only by providers who are experienced in terms of technical skills and selection of patients.
Our findings on the volume-outcome relationship for CEA and CAS procedures are not only in line with the previous reports but also in partial contrast on several points. In fact, substantial methodological heterogeneity limits comparability. Other possible sources of variance possibly influencing the results of this study and those of previously reported investigations (eg, physician-specific annual case load 13, 16, 35 or patient allocation to different providers depending on plaque/vessel morphology or general health risks) must be considered.
Limitations
Although this study is a near-complete (>99%) reflection of CEA and CAS procedures performed in German hospitals over the last 6 years, some important points compromising validity of the results must be assumed for this study. See Methods section in the Data Supplement for an in-depth discussion.
Causality
Patients were not randomized for treatment in hospitals with a predefined annual volume in this retrospective observational study. Although conclusions about the causality of the volume-outcome relationship should be drawn with great caution, these data may be crucial for facilitating evidence-based generation of hypotheses for interventional studies.
Selection Bias
As patients were not randomized, the results may be biased by active or passive selection mechanisms depending on the individual factors intrinsic to the patient or the healthcare provider and (infra)structural conditions of the hospital and region in which it is located. Because these factors are currently not available from routine data, no appropriate adjustment can be made.
Information Bias
All data were self-reported by the treating physicians or delegates of the treating departments; thus, down-coding of adverse events cannot be excluded. Misinformation may be counterbalanced by structured validity checks (performed by the so-called Landesstellen and the AQUA Institute) and hospital audits (comparing the data reported to the database with the original patient records) reporting results that are higher or lower than expected on a semiannual basis. Event rates might also be biased by the length of postprocedural stay. In principal, postprocedural events were documented only when occurring before the discharge from hospital, but early readmission because of disease-related causes may result in case consolidation according to the diagnosis-related group coding rules. There is a slight volume-related trend toward a shorter hospital stay in patients treated with CEA (median 1-2 days; Figure V in the Data Supplement). However, the strength of bias because of different length of stay may be regarded as low. For patients treated with CAS, no clinically relevant volume-related trends of the length of stay were seen ( Figure VI in the Data Supplement). In the CAS group, missing values were consistent across hospital volume categories and have no relevant effect on the results. Although the rate of missing values was heterogeneous across volume categories in the CEA group, RR and CI changed only in the second decimal place when omitting variables that contained missing values. Therefore, in the CEA group, bias because of missing values is also negligible.
Confounding
As no further data on medication or comorbidities (eg, coronary heart disease, diabetes mellitus, hypertension, smoking habits, hyperlipidemia, and statin therapy) were documented, only patients' sex, age, American Society of Anesthesiologists category, and degree of carotid stenosis were available for medical risk adjustment. Therefore, nonconsideration of unobserved confounders (eg, patency of vertebral arteries, patency of the circle of Willis, and plaque morphology) may have also influenced the indication for treatment, the selection of technique, the selective application of intra-arterial shunting, or the decision to delegate the treatment to an experienced physician or to transfer the patient to another hospital. However, major strengths of this study are that (1) data were collected systematically and nationwide on a statutory basis, (2) data were prospectively collected for the primary purpose of disease-specific quality assurance reflecting the real-world situation in Germany, (3) data acquisition did not apply inclusion or exclusion criteria other than the application of either CEA or CAS procedures, and (4) the findings were based on the clinical examinations rather than administrative codes.
Conclusions
This study reveals that there is a significant inverse volumeoutcome relationship in patients treated with CEA under real-life conditions in Germany. For hospitals with higher volumes (quintiles 4 and 5), the risk of any stroke or death did not further decrease with increasing volume. In CAS patients, no volume-outcome association was seen, however, the sample size may have been too low to properly evaluate the volume-outcome relationship for CAS. However, our study might contribute relevant data to the controversial health policy discussion on the centralization of CEA and CAS. However, the most important issues with respect to patients are low (risk adjusted) outcome rates and good long-term results, founded on evidence-based initial decision making concerning the choice of treatment and proper selection of the treating hospital.
